与神经母细胞瘤中MYCN基因放大相关的图像定义风险因素及其与整体存活率的关联
Haoru Wang1, Ting Li1, Xiaoying Ni1
1Department of Radiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, No. 136 Zhongshan Road 2, Yuzhong District, Chongqing, 400014, China.
Abdominal radiology (New York)
|March 4, 2024
概括
图像定义风险因素 (IDRF) 与神经母细胞瘤中MYCN放大相关. 特定的IDRF和更多的IDRF与儿科神经母细胞瘤患者的预后和生存率较差有关.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 儿科医学 儿科医学
背景情况:
- 在神经母细胞瘤的发展和进展中,MYCN瘤基因至关重要.
- 图像定义风险因子 (IDRFs) 在手术前神经母细胞瘤分期的帮助.
- 了解与MYCN放大相关的IDRF对于治疗分层至关重要.
研究的目的:
- 研究与神经母细胞瘤中MYCN放大相关的特定IDRF.
- 确定IDRFs,MYCN放大和整体生存时间之间的关联.
主要方法:
- 对280名儿科神经母细胞瘤患者的回顾性分析.
- 通过分子测试确定MYCN放大状态.
- 通过CT或MRI评估的IDRF,与临床和放射学数据相关联.
主要成果:
- 在19.6%的患者中发现MYCN放大;与较大的瘤体积和更多的IDRF相关.
- 结肠病轴/上半导体动脉封闭和与MYCN放大相关的器官透 (P<0.05).
- 超过四个IDRF与更糟糕的预后相关 (P=0.017);器官透预测的生存率 (P=0.009).
结论:
- IDRF与神经母细胞瘤中MYCN放大状态密切相关.
- 特定的IDRF及其数量影响神经母细胞瘤的整体存活率.
相关概念视频
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


